- Uncontrollable stress in healthcare workers may be a legal hazard, researchers argue
- Baptist Health Richmond names chief medical officer
- 101 hospital and health system chief pharmacy officers to know | 2026
- 21 new behavioral health study findings to know
- 32 behavioral health executive moves to know
- 7 Medicaid behavioral health fraud cases, audit findings to know
- Beyond alarm management: How Elizabeth Seton Children’s Center turned surveillance data into personalized pediatric care
- What’s next for Rush’s retiring CEO
- Healthcare billing fraud: 10 recent cases
- Assort Health raises $120M
- HCA Florida hospital taps COO
- 48 recent hospital, health system executive moves
- How long does it take to sell an ASC?
- Why 34 health systems bet big on GI in 2026
- Lung cancer screening, mortality and incidence — by state
- My Community Dental Centers appoints new CEO
- 42 North Dental appoints chief marketing officer
- Physicians vs. prior authorization: 10 updates
- Physicians, not hospitals, are driving practice acquisitions: Study
- ADA backs federal healthcare workforce bill
- Standard Dental Labs plans acquisition of Florida lab
- The states where physicians earn the most after taxes
- Where 6 cardiology advocacy efforts stand now: ACC
- Leadership training, insurance, bonuses and more: What the best dental workplaces offer employees
- UM Health-Sparrow receives record gift for behavioral health hospital
- US psychiatrist workforce to meet 42.8% of projected demand by 2037: Study
- 14 new behavioral health projects to know
- What hospital-employed physicians regret most after an acquisition: Study
- Heartland Dental opens Ohio practice
- Eugene Gastroenterology Consultants opens new ASC
- CRNAs are leaving hospital jobs — where are they going?
- 5 DSOs making headlines
- 2 physicians pay $2.2M to settle claims of medically unnecessary surgical procedures
- Cancer Drug Shortage Renews Calls For Federal Action
- Next-Generation Blood Test Improves Detection Of Aggressive Prostate Cancer
- As PBM industry shifts, LucyRx and Abarca Health merge to build scale
- FDA slaps Dr. Reddy's Hyderabad biologics plant with seven observations in new Form 483
- Most Patients Want Docs To Break Cancer News Directly, Not Through Portal Messaging
- Sanofi under antitrust probe as European Commission kicks off formal proceedings
- Weekly Rundown: Innovaccer, AWS ink strategic collaboration; Mount Sinai adopts Signal 1 for AI management
- Industry Voices—What Pope Leo’s AI encyclical could mean for healthcare: 3 key takeaways for leaders
- Europe's CHMP reverses endorsement of Tavneos as Amgen FDA hearing looms
- Statins Rarely Cause Severe Muscle Problems, Researchers Say
- Even In Blue States, Hospitals Continue To Drop Gender-Affirming Care For Youths
- Younger U.S. Generations Increasingly Fear Adulthood, Study Says
- Opioid Settlement Money Pays For Services To Battle Addiction In Rural Kentucky
- Trouble Getting Weight Loss Drugs Covered by Insurance? Here’s What To Know
- Efforts To End School Vaccine Mandates Hit a Wall in Florida
- Medicare Advantage Company Pays $342M to Government in Midst of Billing Probe
- Fierce Pharma Asia—Historic solid tumor CAR-T nod; Inside Pfizer, Innovent’s $10B pact; More China deals
- Eli Lilly taps AI to bring personal memories to life during its European radio show road trip
- BeOne boosts support for Blood Cancer United with $5M commitment
- Pharma’s Cannes-do attitude sees industry return to triumph
- Biogen launches ‘Ready for More’ HD Spinraza campaign with a focus on how we see SMA
- Senators revive bill targeting expanded methadone access
- DSOs gain new funding to fuel growth: 3 updates
- Montana hospital to end dental services due to financial constraints
- Rhode Island expands reimbursement options for public health hygienists
- 2 behavioral health providers to affiliate under Boundless name
- 5 states targeting Medicaid behavioral health enrollment amid fraud concerns
- Arizona behavioral health clinic suspended from Medicaid amid fraud allegations
- Cassidy's new plan to overhaul 340B: Rebates, contract pharmacy limits and more changes
- With Medicare's GLP-1 'bridge' coming soon, Walmart expands weight management supports for consumers
- Air Force Outbreak Grows As Military Reinstates Flu-Shot Rule For Recruits
- Bayer scores landmark victory as Supreme Court overturns Roundup verdict
- Democrats to propose bill capping out-of-pocket costs for Medicare enrollees
- Upside secures $20M series A to expand healthcare-focused housing platform
- GLP-1 Weight-Loss Boom Linked To Surge In Poison Control Calls
- Fosun Pharma plots global push beyond oncology, fueled by multi-asset Alzheimer’s strategy
- FDA shines harsh light on Pinnacle after finding fault with photodynamic therapy videos
- Brain Scans Improve Targeting Of Magnetic Stimulation For Depression
- Estrogen Birth Control May Protect Women’s Brains As They Age
- Very Few Men Discuss Prostate Cancer Screening With Their Doctor
- Merck KGaA throws down $11.3B for Bio-Techne in its biggest deal since 2015 Sigma-Aldrich buy
- Severe Pregnancy Nausea Tied To Higher Risk Of Complications
- A Ban Won't Stop Abortion Pill Access, Telehealth Providers Say
- Opioid Settlement Money Pays for Services To Battle Addiction in Rural Kentucky
- Democrats To Propose Bill Capping Out-of-Pocket Medicare Costs for Enrollees
- Oracle partners with Theator to expand AI-powered surgical documentation to operating rooms
- Jubilant HollisterStier gets FDA warning letter for quality control problems
- Ionis scores transformational FDA label expansion for Tryngolza
- AstraZeneca spells out a community cancer screening strategy with the YMCA
- Novartis teams up with Becoming rentABLE for its new SMA campaign
- Assort Health scores $120M series C to scale voice AI agent platform for healthcare
- Kaiser Health Plan ordered to pay hospital $82M over insufficient reimbursement
- TigerConnect expands AI-driven platform with new scheduling capabilities
- US health spending set to reach $9T by 2034: CMS report
- Mapp, Gilead antivirals to be deployed in DRC Ebola trial: WHO chief
- Senators call for $50B rural health fund to better target small providers, relax spending restrictions
- First Stop Health expands weight management program, shares first-year results
- Florida AG to probe CVS for anticompetitive pharmacy practices
- Pfizer scores 1st expansion in 7 years for breast cancer blockbuster Ibrance
- UnitedHealth, Humana And CVS Denied Post-Hospital Care At Some Of The Highest Rates
- Infinitus launches risk detection system to ensure appropriate patient triage from AI agents
- Even 5-Minute Movement Breaks Can Boost Your Mood And Fight Fatigue
- Lilly exec says MFN will affect company's obesity pill launch strategy in Europe: report
- Stada, under new CapVest ownership, picks up horde of European consumer brands
- Belly Laughs Spring From The Primitive Brain, Researchers Say
- Mom's Good Heart Health Lowers Risk Of Baby's Developmental Delays
- Accelerated Aging May Explain Rising Cancer Risk In Young Adults
- Coval raises $28M series A to address AI voice agent reliability, compliance
- Amid safety concerns, ADC Therapeutics plots 17% staff cuts to push resources behind Zynlonta
- Racial Gaps Narrow For U.S. Cancer Deaths, Report Finds
- Medicare's AI Push Snarls Patients And Doctors In Errors And Delays
- Even in Blue States, Hospitals Have Continued To Drop Gender-Affirming Care for Youths
- Patients prefer healthcare providers' AI agents to public chatbots, with human oversight non‑negotiable, survey finds
- Nature retracts provocative PD-1 study that tied lung cancer survival to treatment timing
- Some life insurers compete with health insurers on benefits. Here's why
- DOJ announces $6.5B healthcare fraud takedown with record Medicaid enforcement
- Locum tenens coverage becoming ‘more purposeful’ staffing strategy: Definitive Healthcare
- Testosterone Therapy Labels And Limits May Change Under FDA Proposal
- Midlife Strength Training Linked to Lower Diabetes Risk
- Badges, bots and blind spots
- Patient Portal Messages Double, Doctors Face Rising Workload
- Most Americans Unaware Of Link Between Alcohol And Cancer — And Aren't Interested In Spreading The Word, Either
- Sunscreen Misinformation Popular On TikTok, Study Finds
- Indiana Takes On Powerful Hospitals By Capping Prices They Charge Employers
- Kids’ Juice And Soda Intake Linked To Higher Blood Pressure Risk As Young Adults
- Worried About Your Aging Parents? Welcome to the Caregiving Club
- Medicare’s AI Push Snarls Patients and Doctors in Errors and Delays
- AdvanCell locks in lease for US headquarters, radiopharmaceutical production near Boston
- Clover Hill Dairy Recalls All Cheese in Deadly Listeria Outbreak
- Middle-Aged Women Drink More, Know Less About Breast Cancer Risk
- CMS Proposes TAVR Medicare Coverage is Potential Boost for Edwards Lifesciences
- High Hurdles Thwart Kidney Patients' Pursuit Of Life-Saving Transplants
- Rising Healthcare Costs Leave Many Americans Less Secure
- Short Videos Help First-Time Dads Learn Newborn Safety Basics
- Federal Push To Increase U.S. Primary Care Docs Has Fizzled, Study Says
- They're Uninsured After Obamacare Became Too Costly. And They're Far From Alone.
- Indiana Takes On Powerful Hospitals by Capping Prices They Charge Employers
- Fish Oil Supplements May Be A Bust For Alzheimer's Prevention
- Prehab Can Boost Seniors' Recuperation From Spinal Fusion Surgery, Trial Finds
- Ozempic Might Cut Risk Of Broken Bones, Study Says
- Dog Owners Feel Similar Grief Whether Pets Euthanized, Die Naturally
- Massage Guns Can Cause Eye Damage, Vision Loss, Case Report Warns
- Sandwiched Between Caring for Kids and Aging Parents? Reach Out for Resources
- Gilead’s Trodelvy nabs broad FDA approval in front-line TNBC, fueling TROP2 ADC market war
- Remarks to the US-CEE Connection: Transatlantic Challenges in Law, Business & Policy
- Statement Regarding Minimum Pricing Increments and Access Fee Caps
- Statement at the SEC Open Meeting on the Trade-Through Rule and Locked and Crossed Markets Provisions of Regulation NMS
- Disorder Protection Rule: Statement on the Proposed Amendments to Rule 611 and Other Provisions of Regulation NMS
- Statement on the Proposed Amendments to Regulation NMS
- This Old House: Improving and Remodeling Our Registered Offering and Filer Status Regimes
- Peirce Out: Remarks at the U.S. Chamber of Commerce Capital Markets Summit
- Medtronic Advances Hugo Robotic Surgery Platform with Key FDA Filings and Product Approvals
- Medtronic Posts Strongest Revenue Growth in a Decade, Driven by Cardiovascular and Surgical Businesses
- Boston Scientific Plans Indiana Distribution Center, 300 New Jobs
- “Harmonization: We’ll Have Lots to Talk About”
- Remarks at the Investor Advisory Committee Meeting
- A Quarter for Your Thoughts: Remarks at the Meeting of the SEC Investor Advisory Committee
Michigan healthcare freedom community forum
Think the author of this post has the entities suing the Federal government wrong. It is the Dayton Chamber of Commerce suing, with the backing of the U.S. Chamber of Commerce:
US Chamber of Commerce sues over government's drug pricing power
By Jonathan Stempel - June 9, 2023June 9 (Reuters) - The U.S. Chamber of Commerce on Friday sued the federal government, challenging a new law that for the first time gives Medicare the power to negotiate drug prices with pharmaceutical companies.
In a complaint filed in federal court in Dayton, Ohio, the chamber said the pricing program violated drugmakers' due process rights under the U.S. Constitution by giving the government "unfettered discretion" to dictate maximum prices.
It also said the program would impose exorbitant penalties on drugmakers that don't accept those prices, and amounted to an ultimatum: "agree to whatever price the government names, or we'll smash up your business."
The U.S. Department of Health and Human Services administers Medicare through its Centers for Medicare & Medicaid Services.
A spokeswoman said the agency will vigorously defend the program, which is already helping lower healthcare costs for older adults and people with disabilities. "The law is on our side," she added.
Friday's lawsuit by the chamber, one of the most powerful U.S. business groups, came three days after Merck & Co (MRK.N) filed a similar lawsuit in Washington, D.C.
Both lawsuits contended that price controls would force drugmakers to pull back on developing new drugs, causing long-term harm to Americans and their health.
Other drugmakers have also objected to the pricing program, which is part of last year's Inflation Reduction Act. Pricing changes following negotiations on 10 costly drugs selected by CMS would take effect in 2026.
Americans pay more for prescription drugs than prices in any other country.
The Biden administration hopes to save $25 billion annually by 2031 by having Medicare, the government health plan for people 65 and over, negotiate prices.
White House spokeswoman Karine Jean-Pierre said on Tuesday the government was confident it would win the Merck case.
"There is nothing in the Constitution that prevents Medicare from negotiating lower drug prices," she said.
The chamber also warned that allowing the pricing program would set a bad precedent.
"After all, if the government can impose price controls in the pharmaceutical industry, why not elsewhere?" Chief Policy Officer Neil Bradley said in a statement.
The case is Dayton Area Chamber of Commerce et al v Becerra et al, U.S. District Court, Southern District of Ohio, No. 23-00156.
Now up to 4 Pharma/Chamber of Commerse lawsuits contesting Medicare drug price negotiation.
Pharmaceutical trade group sues US over Medicare drug price negotiation plans
NEW YORK, June 21 (Reuters) - The Pharmaceutical Research and Manufacturers of America (PhRMA), the leading industry lobby group, and two other organizations on Wednesday said they were suing the U.S. government to block enforcement of a program that gives Medicare the power to negotiate drug prices.
In a complaint filed in a federal court in Texas, PhRMA along with the National Infusion Center Association and the Global Colon Cancer Association, which counts PhRMA and some drug companies as members, said the drug price negotiation program was unconstitutional.
This marks the fourth lawsuit challenging the law, which is part of President Joe Biden’s signature Inflation Reduction Act (IRA), after separate legal challenges by Merck & Co (MRK.N), Bristol Myers Squibb (BMY.N), and the influential business group the U.S. Chamber of Commerce.
The pharmaceutical industry claims negotiating prices of its products with the government health plan for Americans age 65 and older will curtail profits and compel them to pull back on developing groundbreaking new treatments.
PhRMA represents many of the largest pharmaceutical companies in the world, including Merck and Bristol Myers.
Americans pay more for prescription medicines than any other country. The Biden administration's drug pricing reform aims to save $25 billion annually by 2031 through price negotiations for the drugs most costly to Medicare.
The latest lawsuit argues that the "unrestrained authority" given to the Department for Health and Human Services (HHS) by Congress conflicts with the United States' separation-of-power principle.
"Congress took a series of unconstitutional shortcuts, giving the executive branch the open ended task of replacing market based prices in Medicare with an entirely new set of prices at the (Medicare) agency's own choosing," PhRMA general counsel James Stansel said at a press conference.
The lawsuit also contends that the price negotiation program violates the U.S. Constitution's Eight Amendment, which protects against excessive fines, and Fifth Amendment by exempting key decisions from public input.
PhRMA and the other two groups are seeking an injunction against the price caps and a declaration that the IRA's price negotiation is unconstitutional.
The negotiations are scheduled to start in September after the agency that runs Medicare and Medicaid releases its list of 10 costly drugs initially selected for the process, with the agreed prices taking effect in 2026.
The suits challenging the plan have been filed in four different federal courts, with Merck's in Washington, D.C., the Chamber of Commerce in Ohio and Bristol Myers' in New Jersey.
In response to the previous lawsuits, the White House said there is nothing in the U.S. Constitution that prevents Medicare from negotiating lower drug prices.
A spokesperson for HHS on Wednesday said the law is on its side.
“As the (HHS) secretary has already made clear, we will vigorously defend the president’s drug price negotiation law, which is already helping to lower healthcare costs for seniors and people with disabilities."
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.
Sponsors
J & DE Family Charitable Fund
Friends
of MHF
Kelly Grotendiek
Philip Harbach
Dale Johnson
Drs. Jeffrey and Joni Jones
Vickie Kahle
Tammy Kipen
Marlin & Kathy Klumpp
Melanie Kurdys
Ruth Nobel
Patrick Peterson
Stephanie Poortenga
Jeanne Smit
Ben and Hope Staal
John Tuinstra
Jacki VanHuis
Sandy Walker
Sign Up for MHF Insights to keep up on the latest in Michigan Health Policy
